Atlas Arteria Management and Advisory Agreements
Atlas Arteria was externally managed by Macquarie Fund Advisors Pty Limited (MAF) until 31 March 2019. ATLAX and ATLIX terminated the Management/Advisory Agreements on 1 April 2019 and management of Atlas Arteria transitioned to its current management team.
In accordance with the terms of the Atlas Arteria Management/Advisory Agreements base fees were paid to MFA until 15 May 2019.
Additionally, ATLAX and ATLIX entered into a Transition Services Agreement with the MFA from 16 May 2019 until 31 December 2019 for a monthly fee of $750,000.
Asset level management and performance fees were payable by Atlas Arteria to Macquarie from 16 May 2019 in respect of Atlas Arteria’s investment in APRR, until 2 March 2020 when Macquarie's management of the APRR Investment was terminated. Macquarie continues to provide transition services on the APRR Investment, but at no cost to Atlas Arteria.